Bridget C Griffith
Biographic Data
| ID | 7748887 |
|---|---|
| NAME | Bridget C Griffith |
| GIVEN NAMES | Bridget C |
| FAMILY NAME | Griffith |
| SIGNATURE | GRIFFITH B C |
| AFFILIATIONS | Clinton Health Access Initiative |
| ORCID | 0000-0003-4804-7919 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Assessing the impact of a gender-neutral approach to HPV vaccination on vaccination coverage for nine-year-old girls in Cameroon
Cameroon introduced the human papilloma virus vaccine (HPVV) into the routine immunization schedule in October 2020. By the end of 2022, coverage remained low. To increase coverage, Cameroon switched to a country-wide, gender-neutral vaccination (GNV) approach in 2023, coupled with a revamped delivery strategy of Community Dialogues (CDs) and Periodic Intensification of Routine Immunization (PIRIs) activities in selected health districts (HDs). W…
Policies and strategies for HPV vaccination schedule completion in immunocompromised girls, including girls living with HIV
Immunocompromised girls, including girls living with HIV, face significantly increased risk for HPV-linked cervical cancer and require a differentiated human papillomavirus (HPV) vaccination schedule. While World Health Organization (WHO) vaccination guidelines exist, recommending immunocompromised individuals receive at least two, if possible three doses of HPV vaccine, little is known about how country health programs implement these recommenda…
Perceptions of a gender-neutral approach to human papillomavirus (HPV) vaccination in Cameroon
Cameroon’s Expanded Program on Immunization (EPI) introduced the HPV vaccine into the routine immunization schedule in Cameroon in October 2020. However, coverage for this vaccine was just 20% by December 2022, prompting the government to adopt and implement a gender-neutral vaccination (GNV) from January 2023. The goal was to increase acceptance, reduce stigma, and improve vaccine coverage. This study aimed to assess the perceptions of key immun…
Rapid establishment of public sector Covid-19 test-and-treatment programmes across seven low- and middle-income countries
The COVID-19 Treatment QuickStart Consortium worked with governments in seven low- and middle-income countries (LMICs), Ghana, Laos, Malawi, Nigeria, Rwanda, Uganda and Zambia, to implement COVID-19 test-and-treat programmes at 776 health facilities, including training over 5000 staff and facilitating a donation of 11 300 courses of the oral antiviral nirmatrelvir/ritonavir for treatment. This paper describes the process of implementing COVID-19 …
Does mothers’ and caregivers' access to information on their child’s vaccination card impact the timing of their child’s measles vaccination in Uganda
Mothers'/caregivers' ability to identify key pieces of information on their child's vaccination card was not associated with achieving on-time MCV1 vaccination. Further research can shed light on interventions that may prompt or remind mothers/caregivers of the time and age when their child is due for measles vaccine to increase the chance of the child receiving it at the recommended time
No prominent works on this page.
Does mothers’ and caregivers' access to information on their child’s vaccination card impact the timing of their child’s measles vaccination in Uganda
Mothers'/caregivers' ability to identify key pieces of information on their child's vaccination card was not associated with achieving on-time MCV1 vaccination. Further research can shed light on interventions that may prompt or remind mothers/caregivers of the time and age when their child is due for measles vaccine to increase the chance of the child receiving it at the recommended time
Rapid establishment of public sector Covid-19 test-and-treatment programmes across seven low- and middle-income countries
The COVID-19 Treatment QuickStart Consortium worked with governments in seven low- and middle-income countries (LMICs), Ghana, Laos, Malawi, Nigeria, Rwanda, Uganda and Zambia, to implement COVID-19 test-and-treat programmes at 776 health facilities, including training over 5000 staff and facilitating a donation of 11 300 courses of the oral antiviral nirmatrelvir/ritonavir for treatment. This paper describes the process of implementing COVID-19 …
Assessing the impact of a gender-neutral approach to HPV vaccination on vaccination coverage for nine-year-old girls in Cameroon
Cameroon introduced the human papilloma virus vaccine (HPVV) into the routine immunization schedule in October 2020. By the end of 2022, coverage remained low. To increase coverage, Cameroon switched to a country-wide, gender-neutral vaccination (GNV) approach in 2023, coupled with a revamped delivery strategy of Community Dialogues (CDs) and Periodic Intensification of Routine Immunization (PIRIs) activities in selected health districts (HDs). W…
Policies and strategies for HPV vaccination schedule completion in immunocompromised girls, including girls living with HIV
Immunocompromised girls, including girls living with HIV, face significantly increased risk for HPV-linked cervical cancer and require a differentiated human papillomavirus (HPV) vaccination schedule. While World Health Organization (WHO) vaccination guidelines exist, recommending immunocompromised individuals receive at least two, if possible three doses of HPV vaccine, little is known about how country health programs implement these recommenda…
Perceptions of a gender-neutral approach to human papillomavirus (HPV) vaccination in Cameroon
Cameroon’s Expanded Program on Immunization (EPI) introduced the HPV vaccine into the routine immunization schedule in Cameroon in October 2020. However, coverage for this vaccine was just 20% by December 2022, prompting the government to adopt and implement a gender-neutral vaccination (GNV) from January 2023. The goal was to increase acceptance, reduce stigma, and improve vaccine coverage. This study aimed to assess the perceptions of key immun…
Public health (4 works) · Vaccination (4 works) · Cervical Cancer and HPV Research (3 works) · Vaccination schedule (3 works) · Vaccine Coverage and Hesitancy (3 works) · Health care (2 works) · Immunization (2 works) · Population (2 works) · Qualitative research (2 works) · Schedule (2 works)